Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1420619
European Journal of Endocrinology, Vol 142, Issue 6, 619
Copyright © 2000 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Picon, M.
Right arrow Articles by Rovira, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Picon, M.
Right arrow Articles by Rovira, A
Case Reports

Use of a long-acting gonadotrophin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour

MJ Picon, JI Lara, JL Sarasa, JD Recasens, R Clouet, MA Gonzalo, and A Rovira

Department of Endocrinology, Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Madrid, Spain.

OBJECTIVE: The aim of this study was to prove the utility of GnRH analogues for the suppression of androgen secretion in a postmenopausal woman with a suspected virilizing ovarian tumour. DESIGN AND METHODS: We present a case of a 72-year-old woman with virilization of recent onset. Hormonal studies revealed a fourfold increase in serum testosterone levels, normal dehydroepiandrosterone sulphate concentrations and high levels of serum 17-hydroxyprogesterone levels. Computed axial tomography scan of the ovaries was normal and the adrenal glands showed a discrete enlargement. The long-acting GnRH analogue, triptorelin, was injected initially (3.75mg i.m.) and serum hormone levels were measured weekly throughout one month. RESULTS: GnRH produced a decrease in serum testosterone levels to normal values, in parallel with the suppression of serum LH and FSH concentrations. The patient was treated for three months with triptorelin and she experienced an amelioration of the hyperandrogenic symptoms. In order to achieve a diagnosis, the patient was submitted to a laparotomy that revealed a small hilus cell tumour in the left ovary. CONCLUSION: GnRH analogues may offer a good therapeutic option in some states of gonadotrophin-dependent hyperandrogenism of ovarian origin.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
H. de Boer, M. de Man, K. de Bruyn, and A. van Sorge
Cetrorelix suppression test to assess the source of androgen overproduction in postmenopausal hirsutism
Eur. J. Endocrinol., September 1, 2006; 155(3): 391 - 393.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. O. Goodarzi, D. W. Dawson, X. Li, Z. Lei, P. Shintaku, C. V. Rao, and A. J. Van Herle
Virilization in Bilateral Macronodular Adrenal Hyperplasia Controlled by Luteinizing Hormone
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 73 - 77.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J.W. Stephens, J.R. Katz, N. McDermott, A.B. MacLean, and P-M.G. Bouloux
An unusual steroid-producing ovarian tumour: Case report
Hum. Reprod., June 1, 2002; 17(6): 1468 - 1471.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 European Society of Endocrinology.